Diligence memo · auto-generated · as of July 2, 2026

CasaHealth Tech Inc.

CasaHealth Tech Inc. looks fair against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

CasaHealth Tech Inc. operates in Pharmaceuticals, based in SURREY.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

CasaHealth Tech Inc. has raised $245K in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).

Largest single filing: $245K on 2019-02-15.

Most recent recorded round closed around 2019-02-15.

Valuation (modeled)modeled

Provath models CasaHealth Tech Inc. at approximately $12M (range $137K–$131M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 0.87× the median modeled value of Pre-Seed Pharmaceuticals companies in 2019–2021 (46 peers) — value vs value, same stage and era. Within the normal band (87% of peer median) for its niche.

Financing rhythm & timingmixed

Last raise 7.4 yr ago; this sector typically re-raises about every 13 months.

Only one round on record and long silent — often defunct, acquired, or gone quiet.

Comparablesmixed

Capital scale ranks ahead of 6% of Pharmaceuticals peers (1613 compared).

Modeled value ranks above 19% of those peers.

Closest niche peers: Elion Oncology, Inc., Cyclone Therapeutics, Inc., Sonnet Biotherapeutics, Inc., Fastball Capital Group, Llc, TamRx, LLC.

Peoplefiled

3 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.